These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
85 related items for PubMed ID: 2671932
61. Membranous nephropathy after bone marrow transplantation in ciclosporin treatment. Müller GA, Müller CA, Markovic-Lipkowski J, Bross-Bach U, Schmidt H, Ehninger G, Bohle A, Risler T. Nephron; 1989; 51(4):555-6. PubMed ID: 2662038 [No Abstract] [Full Text] [Related]
62. Chronic Graft-versus-Host Disease: A Long Road Ahead. Anand S, Sarantopoulos S. Biol Blood Marrow Transplant; 2018 Mar; 24(3):423-424. PubMed ID: 29353108 [No Abstract] [Full Text] [Related]
63. IL-27: a new target for GVHD prevention. Fowler DH, Amarnath S. Blood; 2016 Oct 20; 128(16):2003-2004. PubMed ID: 28157677 [Abstract] [Full Text] [Related]
65. Role of immunosuppressive drugs for prevention of graft-v-host disease after bone marrow transplantation. Devergie A, Esperou H, Traineau R, Varrin F, Lehn P, Gluckman E. Nouv Rev Fr Hematol (1978); 1989 Oct 20; 31(2):73-5. PubMed ID: 2671932 [Abstract] [Full Text] [Related]
67. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease. Aschan J, Ringdén O. Clin Transplant; 1994 Jun 20; 8(3 Pt 1):258-70. PubMed ID: 8061365 [Abstract] [Full Text] [Related]
71. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft. Herrera C, Torres A, García-Castellano JM, Roman J, Martin C, Serrano J, Falcon M, Alvarez MA, Gomez P, Martinez F. Bone Marrow Transplant; 1999 Mar 20; 23(5):443-50. PubMed ID: 10100557 [Abstract] [Full Text] [Related]
72. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease. Aschan J, Ringdén O. Clin Transplant; 1994 Jun 20; 8(3 Pt 1):258-70. PubMed ID: 8061365 [Abstract] [Full Text] [Related]
73. Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy. Aschan J, Ringdén O, Sundberg B, Gahrton G, Ljungman P, Winiarski J. Bone Marrow Transplant; 1991 Feb 20; 7(2):113-9. PubMed ID: 2049554 [Abstract] [Full Text] [Related]
74. Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients. Ringdén O, Pihlstedt P, Markling L, Aschan J, Båryd I, Ljungman P, Lönnqvist B, Tollemar J, Janossy G, Sundberg B. Bone Marrow Transplant; 1991 Mar 20; 7(3):221-6. PubMed ID: 2059758 [Abstract] [Full Text] [Related]